|
|||
| |||||||||||||||||||||||||||||||||||||||
A 57-year-old man came to this hospital for bladder-sparing treatment of invasive transitional-cell carcinoma of the bladder.
He had had a slight burning sensation on urination for six months, and then he observed gross hematuria. Cystoscopy at another institution revealed a midline, posterior-wall mass, 3.0 by 3.0 by 1.4 cm, that involved the left ureteral orifice and that extended to the left lateral bladder wall. The mass was resected by the transurethral route, and pathological examination revealed transitional-cell carcinoma, grade 3 of 3, with invasion of the muscularis propria (Figure 1). There was invasion of the prostatic urethra,
Pathological Discussion
Management Discussion
Surgical Management of Invasive Bladder Cancer
Bladder-Sparing Therapy for Invasive Bladder Cancer
Outcomes of Bladder-Sparing Therapy
Anatomical Diagnosis
Source Information
From the Division of HematologyOncology (D.S.K.) and the Departments of Radiation Oncology (W.U.S.), Urology (W.S.M.), and Pathology (R.H.Y.), Massachusetts General Hospital; and the Departments of Medicine (D.S.K.), Radiation Oncology (W.U.S.), Urology (W.S.M.), and Pathology (R.H.Y.), Harvard Medical School.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |